ELUTIA INC. — Director's Dealing 2020

Oct 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2020-10-07

Reporting Person: Ferguson Matthew (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-07	Stock Option (Right to Buy)	$17.00	A	81800	Acquired	2030-10-06	Class A Common Stock (81800)	Direct

Footnotes

F1: This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020.